BioNumerik Pharmaceuticals Inc - Company Review
BioNumerik Pharmaceuticals Inc - Company ReviewSummary
BioNumerik Pharmaceuticals Inc (BioNumerik) is a developer of novel drugs for the treatment of cancer. The company provides tavocept, karenitecin and preclinical products. Its tavocept, a drug candidate which change the standard of care for women with lung cancer and many other forms of cancer and also oncology and non-oncology indications. BioNumerik's karenitecin offers anti-tumor drugs in the camptothecin class of chemotherapy drugs that is used in the area of patients with advanced ovarian cancer. The company also provides preclinical development programs in the areas of DNA methyltransferase modulators. It offers mecahnism-based drug discovery in multi-disciplinary science including chemistry, biology and quantum physics. BioNumerik is headquartered in San Antonio, Texas, the US.
This comprehensive company report of BioNumerik Pharmaceuticals Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.